United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,647 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 3098,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "032b1bca-e0d8-4882-ad71-bd433d833efd",
"title": "IRADIMED CORPORATION (IRMD) Q3 2024 Earnings Call Transcript",
"description": "IRADIMED CORPORATION. (NASDAQ:IRMD) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ETCompany ParticipantsRoger Susi - President and Chief...",
"keywords": "",
"snippet": "IRADIMED CORPORATION. (NASDAQ:IRMD) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET\n\nCompany Participants\n\nRoger Susi - President and Chief Execut...",
"url": "https://seekingalpha.com/article/4731854-iradimed-corporation-irmd-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T23:52:17.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "IRMD",
"name": "IRadimed Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 130.35063,
"sentiment_score": 0.161683,
"highlights": [
{
"highlight": "<em>IRADIMED</em> <em>CORPORATION</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:IRMD</em>) Q3 2024 Earnings [+337 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Earlier, <em>IRadimed</em> released its [+192 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IRadimed</em> reminds you that the f[+102 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "I would like to turn the call over to Ro[+152 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "<em>IRADIMED</em> <em>CORPORATION</em> (IRMD) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "f6977c7a-24a4-4c4f-af62-e93211dd2c7f",
"title": "Entergy Corporation (ETR) Q3 2024 Earnings Call Transcript",
"description": "Entergy Corporation (NYSE:ETR) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ETCompany ParticipantsLiz Hunter - VP, IRAndrew Marsh - Chairman...",
"keywords": "",
"snippet": "Entergy Corporation (NYSE:ETR) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET\n\nCompany Participants\n\nLiz Hunter - VP, IR\n\nAndrew Marsh - Chairman...",
"url": "https://seekingalpha.com/article/4731795-entergy-corporation-etr-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T21:31:05.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ETR",
"name": "Entergy Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 118.31388,
"sentiment_score": 0.164925,
"highlights": [
{
"highlight": "<em>Entergy</em> <em>Corporation</em> (<[+348 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "And I will now turn the call over to Liz[+301 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Entergy</em> does not assume any obl[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Entergy</em> <em>Corporation</em> (ETR) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ETY.DE",
"name": "Entergy Corporation",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Utilities",
"match_score": 104.01038,
"sentiment_score": 0.164925,
"highlights": [
{
"highlight": "<em>Entergy</em> <em>Corporation</em> (N[+339 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "And I will now turn the call over to Liz[+301 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Entergy</em> does not assume any obl[+300 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Entergy</em> <em>Corporation</em> (ETR) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "02bea52d-9ff8-45c7-9706-03af8994ebc2",
"title": "Sabre Corporation (SABR) Q3 2024 Earnings Call Transcript",
"description": "Sabre Corporation (NASDAQ:SABR) Q3 2024 Earnings Conference Call October 31, 2024 9:00 AM ETCompany ParticipantsBrian Evans - Senior Vice President,...",
"keywords": "",
"snippet": "Sabre Corporation (NASDAQ:SABR) Q3 2024 Earnings Conference Call October 31, 2024 9:00 AM ET\n\nCompany Participants\n\nBrian Evans - Senior Vice President, Investo...",
"url": "https://seekingalpha.com/article/4731687-sabre-corporation-sabr-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:52:08.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SABR",
"name": "Sabre Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 114.40909,
"sentiment_score": 0.265975,
"highlights": [
{
"highlight": "<em>Sabre</em> <em>Corporation</em> (<em[+344 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "& Company\n\nVictor Cheng - Bank of Americ[+104 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "A slide presentation, which accompanies [+193 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sabre</em> <em>Corporation</em> (SABR) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "SABRP",
"name": "Sabre Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 99.38564,
"sentiment_score": 0.265975,
"highlights": [
{
"highlight": "<em>Sabre</em> <em>Corporation</em> (NAS[+335 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "& Company\n\nVictor Cheng - Bank of Americ[+104 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "A slide presentation, which accompanies [+193 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sabre</em> <em>Corporation</em> (SABR) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 25.129562,
"sentiment_score": 0.128,
"highlights": [
{
"highlight": "Sabre Corporation (NASDAQ:SABR) Q3 2024 [+335 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "c45c3d3e-cd7d-40d2-9629-f562dd335ec0",
"title": "SolarWinds Corporation (SWI) Q3 2024 Earnings Call Transcript",
"description": "SolarWinds Corporation (NYSE:SWI) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsTim Karaca - Vice President,...",
"keywords": "",
"snippet": "SolarWinds Corporation (NYSE:SWI) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET\n\nCompany Participants\n\nTim Karaca - Vice President, Finance\n\nSudh...",
"url": "https://seekingalpha.com/article/4731636-solarwinds-corporation-swi-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:08:06.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 25.133291,
"sentiment_score": -0.5574,
"highlights": [
{
"highlight": "SolarWinds Corporation (NYSE:SWI) Q3 202[+330 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SWI",
"name": "SolarWinds Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 118.16394,
"sentiment_score": 0.2096,
"highlights": [
{
"highlight": "<em>SolarWinds</em> <em>Corporation</em>[+339 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "At this time, I would like to welcome ev[+254 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "And welcome to the <em>SolarWinds</em> t[+304 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "<em>SolarWinds</em> <em>Corporation</em> (SWI) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "ac15fc6d-ba67-490c-8715-551a53cad971",
"title": "HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS By Investing.com",
"description": "HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS",
"keywords": "",
"snippet": "Total Revenue Increased 34% YOY to $290 million and Royalty Revenue Increased 36% YOY to $155 million\n\nNet Income Increased 67% YOY to $137 million and Adjusted...",
"url": "https://www.investing.com/news/press-releases/halozyme-reports-third-quarter-2024-financial-and-operating-results-93CH-3696153",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T23:44:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ATRS",
"name": "Antares Pharma, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 7.807089,
"sentiment_score": 0.43895,
"highlights": [
{
"highlight": "114,866\n\n\n\n\n\n(1) Amount relates to fair [+328 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pharma</em> (NASDAQ: ), Inc.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "0be2b83d-65fa-406f-bf7f-cccab60338ee",
"title": "Silvercrest Asset Management Group Inc. Reports Q3 2024 Results By Investing.com",
"description": "Silvercrest Asset Management Group Inc. Reports Q3 2024 Results",
"keywords": "",
"snippet": "NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the Company or Silvercrest) today reported the results of it...",
"url": "https://www.investing.com/news/press-releases/silvercrest-asset-management-group-inc-reports-q3-2024-results-93CH-3696146",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T23:36:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "SAMG",
"name": "Silvercrest Asset Management Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 198.81682,
"sentiment_score": 0,
"highlights": [
{
"highlight": "NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE)[+237 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Silvercrest</em> <em>Asset</em> <em>[+208 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Asset</em> <em>Management</em> <em>G[+23 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Exhibit 3\n\n<em>Silvercrest</em> <em>Asse[+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Exhibit 4\n\n<em>Silvercrest</em> <em>Asse[+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Asset</em> <em>Management</em> <em>G[+24 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Asset</em> <em>Management</em> <em>G[+23 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Asset</em> <em>Management</em> <em>G[+23 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Asset</em> <em>Management</em> <em>G[+23 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Exhibit 9\n\n<em>Silvercrest</em> <em>Asse[+55 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Silvercrest</em> <em>Asset</em> <em>Management</em> <em>Group</em> <em>Inc</em>. Reports Q3 2024 Results By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FRGAP",
"name": "Franchise Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 4.746974,
"sentiment_score": 0.0874,
"highlights": [
{
"highlight": "We define Adjusted EBITDA as EBITDA with[+319 characters]",
"sentiment": -0.7912,
"highlighted_in": "main_text"
},
{
"highlight": "Adjusted EBITDA Measure (Unaudited and i[+333 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "thousands, except per share amounts or a[+335 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "c3bf1a9c-bc95-4148-927b-4ee8579cc687",
"title": "Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update By Investing.com",
"description": "Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update",
"keywords": "",
"snippet": "“ Successful closing of exclusive worldwide licensing agreement with Sanofi (NASDAQ: ) for three potential best-in-class clinical-stage dual-masked T-cell eng...",
"url": "https://www.investing.com/news/press-releases/vir-biotechnology-reports-third-quarter-2024-financial-results-and-provides-corporate-update-93CH-3696080",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T22:48:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ALNY",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.311198,
"sentiment_score": 0.4767,
"highlights": [
{
"highlight": "It is the first asset in Vir's collabora[+261 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VIR",
"name": "Vir Biotechnology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 83.04585,
"sentiment_score": 0.241044,
"highlights": [
{
"highlight": "ET “\n\nSAN FRANCISCO--(BUSINESS WIRE)--[+239 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Jason brings a wealth of financial leade[+313 characters]",
"sentiment": 0.8979,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Vir</em> <em>Biotechnology</em[+255 characters]",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>VIR</em> <em>BIOTECHNOLOGY</em>, <em[+10 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "issued and outstanding as of September 3[+323 characters]",
"sentiment": 0.7627,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BIOTECHNOLOGY</em>, <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Weighted-average shares outstanding, bas[+330 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Biotechnology</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Vir</em> <em>Biotechnology</em> Reports Third Quarter 2024 Financial Results and Provides Corporate Update By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "DUL.DE",
"name": "Alnylam Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 11.875412,
"sentiment_score": 0.4767,
"highlights": [
{
"highlight": "It is the first asset in Vir's collabora[+261 characters]",
"sentiment": 0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XNCR",
"name": "Xencor, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 7.88601,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Tobevibart, which incorporates <em>Xenco[+188 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "759212f5-f4c7-4ebc-ac4e-f34916b56e71",
"title": "Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance By Investing.com",
"description": "Sabra Reports Third Quarter 2024 Results; Updates 2024 Guidance",
"keywords": "",
"snippet": "TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT (NYSE: ), Inc. (Sabra, the Company or we) (Nasdaq: SBRA) today announced its results of operations for t...",
"url": "https://www.investing.com/news/press-releases/sabra-reports-third-quarter-2024-results-updates-2024-guidance-93CH-3696084",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T22:44:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "SBRA",
"name": "Sabra Health Care REIT, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 51.26804,
"sentiment_score": 0.10208,
"highlights": [
{
"highlight": "--(BUSINESS WIRE)--<em>Sabra</em> <em>He[+185 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>SABRA</em> <em>HEALTH</em> <em>CARE<[+33 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>SABRA</em> <em>HEALTH</em> <em>CARE<[+33 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Straight-line rental income 1,119 796 3,[+325 characters]",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HEALTH</em> <em>CARE</em> <em>REIT</[+18 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "and outstanding as of September 30, 2024[+325 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HEALTH</em> <em>CARE</em> <em>REIT</[+18 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": ", beginning of period 46,719 53,932 Cash[+326 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>HEALTH</em> <em>CARE</em> <em>REIT</[+18 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "View source version on businesswire.com:[+222 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "80e5a64a-84eb-43c7-b3ae-44c5fe90006b",
"title": "Olympic Steel Reports Third-Quarter 2024 Results By Investing.com",
"description": "Olympic Steel Reports Third-Quarter 2024 Results",
"keywords": "",
"snippet": "Company's diversification strategy continues to drive results in difficult market conditions\n\nCompany has the strategic focus and financial flexibility to furth...",
"url": "https://www.investing.com/news/press-releases/olympic-steel-reports-thirdquarter-2024-results-93CH-3695935",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T21:24:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZEUS",
"name": "Olympic Steel, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Basic Materials",
"match_score": 77.64264,
"sentiment_score": 0.338255,
"highlights": [
{
"highlight": "Company's diversification strategy conti[+253 characters]",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>ZEUS</em>), a lead[+301 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Marabito concluded, Overall, we believe [+259 characters]",
"sentiment": 0.9246,
"highlighted_in": "main_text"
},
{
"highlight": "Despite near-term market challenges, we [+273 characters]",
"sentiment": 0.7361,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Olympic</em> <em>Steel</em>, <em>Inc[+134 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Olympic</em> <em>Steel</em>\n\nF[+341 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Olympic</em> <em>Steel</em>, <em>Inc[+6 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Steel</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Steel</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Manson\n\nChief Financial Officer\n\n(216) 6[+80 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Olympic</em> <em>Steel</em> Reports Third-Quarter 2024 Results By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "791701ac-1805-4e49-b84e-7296ecdacb49",
"title": "CubeSmart Reports Third Quarter 2024 Results",
"description": "MALVERN, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced its operating results for the three and nine months ended...",
"keywords": "NYSE:CUBE, CubeSmart",
"snippet": "MALVERN, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) today announced its operating results for the three and nine months ended September 30, 2...",
"url": "https://www.globenewswire.com/news-release/2024/10/31/2973065/0/en/CubeSmart-Reports-Third-Quarter-2024-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b4a5ab1c-e832-4a24-9061-363fb0731dd0",
"language": "en",
"published_at": "2024-10-31T20:30:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "LAACZ",
"name": "LAACO, Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Real Estate",
"match_score": 10.303169,
"sentiment_score": 0.2997,
"highlights": [
{
"highlight": "and units outstanding 228,386 227,614 22[+326 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>Ltd</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "055a98f2-0a8b-4e67-a3c0-5cebaec9d6f5",
"title": "SGX Introduces 5 New Hong Kong Singapore Depository Receipts: Here’s What You Need to Know",
"description": "These five stocks help to expand SGX’s suite of Singapore Depository Receipts and offer investors more exposure to regional stocks.",
"keywords": "",
"snippet": "It’s been more than 15 months since Singapore Exchange Limited (SGX: S68), or SGX, introduced its first set of Singapore Depository Receipts (SDRs).\n\nSDRs are...",
"url": "https://thesmartinvestor.com.sg/sgx-introduces-5-new-hong-kong-singapore-depository-receipts-heres-what-you-need-to-know/",
"image_url": "https://thesmartinvestor.com.sg/wp-content/uploads/2024/10/SGX2.png",
"language": "en",
"published_at": "2024-10-31T23:30:00.000000Z",
"source": "thesmartinvestor.com.sg",
"relevance_score": null,
"entities": [
{
"symbol": "SPXCF",
"name": "Singapore Exchange Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 25.796291,
"sentiment_score": 0.148,
"highlights": [
{
"highlight": "It’s been more than 15 months since <e[+137 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Disclosure: Royston Yang owns shares of [+54 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SPXCY",
"name": "Singapore Exchange Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 25.796303,
"sentiment_score": 0.148,
"highlights": [
{
"highlight": "It’s been more than 15 months since <e[+137 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Disclosure: Royston Yang owns shares of [+54 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DLEGF",
"name": "DELTA ELECTRONICS",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 17.563988,
"sentiment_score": 0.6486,
"highlights": [
{
"highlight": "The stocks are Advanced Info Services (S[+323 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c2b83e9f-9840-4056-8d81-f4fc7c89be0e",
"title": "BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024 By Investing.com",
"description": "BioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024",
"keywords": "",
"snippet": "BOTHELL, Wash. , Oct. 31, 2024 /PRNewswire/ -- BioLife Solutions (NASDAQ: ), Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and...",
"url": "https://www.investing.com/news/press-releases/biolife-solutions-to-report-third-quarter-2024-financial-results-and-business-update-on-november-12-2024-93CH-3696124",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T23:28:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "BLFS",
"name": "BioLife Solutions, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 76.579025,
"sentiment_score": 0,
"highlights": [
{
"highlight": ". , Oct. 31, 2024 /PRNewswire/ -- <em>Bi[+46 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ</em>: <em>BLFS</em>), a lead[+271 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "To access the webcast, log onto the Inve[+249 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>BioLife</em> <em>Solutions</em[+180 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>BioLife</em> <em>Solutions</em> to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024 By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "23791aac-27d3-41d4-9b7f-5e26477122dc",
"title": "Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 By Investing.com",
"description": "Schrödinger to Announce Third Quarter 2024 Financial Results on November 12",
"keywords": "",
"snippet": "NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are disc...",
"url": "https://www.investing.com/news/press-releases/schradinger-to-announce-third-quarter-2024-financial-results-on-november-12-93CH-3695422",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T18:16:05.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "SDGR",
"name": "Schrödinger, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 61.4348,
"sentiment_score": 0,
"highlights": [
{
"highlight": "NEW YORK--(BUSINESS WIRE)--Schrödinge[+329 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Schrödinger</em> to Announce Third Quarter 2024 Financial Results on November 12 By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "15c3eb47-54bb-489c-9e34-81fe702f3275",
"title": "L.B. Foster Company to Report Third Quarter 2024 Results on November 7, 2024 By Investing.com",
"description": "L.B. Foster Company to Report Third Quarter 2024 Results on November 7, 2024",
"keywords": "",
"snippet": "PITTSBURGH, Oct. 31, 2024 (GLOBE NEWSWIRE) -- L.B. Foster Company (NASDAQ: FSTR, the Company), today announced that it will release its third quarter results, p...",
"url": "https://www.investing.com/news/press-releases/lb-foster-company-to-report-third-quarter-2024-results-on-november-7-2024-93CH-3695059",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T16:12:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "FSTR",
"name": "L.B. Foster Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 163.57858,
"sentiment_score": 0.17916,
"highlights": [
{
"highlight": "PITTSBURGH, Oct. 31, 2024 (GLOBE NEWSWIR[+227 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Foster</em> will host a conference c[+275 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>L.B</em>. <em>Foster</em> <em>[+210 characters]",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Investor Relations:\n\nLisa Durante\n\n(412)[+189 characters]",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "<em>L.B</em>. <em>Foster</em> <em>Company</em> to Report Third Quarter 2024 Results on November 7, 2024 By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "da89afb3-07cf-4d3c-ab07-c29a5f7687db",
"title": "PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results By Investing.com",
"description": "PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results",
"keywords": "",
"snippet": "PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024. The Company also filed its Quarterly R...",
"url": "https://www.investing.com/news/press-releases/prodex-inc-announces-fiscal-2025-first-quarter-results-93CH-3696128",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T23:28:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "PDEX",
"name": "Pro-Dex, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 129.5098,
"sentiment_score": 0.233289,
"highlights": [
{
"highlight": "<em>PRO</em>-<em>DEX</em>, <em>INC</em>.[+267 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Pro</em>-<em>Dex</em> (NASDAQ:[+274 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pro</em>-<em>Dex</em> also sells com[+226 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(tables follow)\n\n<em>PRO</em>-<em>DEX</e[+17 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "23,431 21,610 Shareholders' Equity: Comm[+334 characters]",
"sentiment": 0.8519,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "taxes 853 (214 ) Net income (loss) $ 2,4[+334 characters]",
"sentiment": 0.9517,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>INC</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>PRO</em>-<em>DEX</em>, <em>INC</em>. Announces Fiscal 2025 First Quarter Results By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "0f13c1cc-b824-4dce-b2d8-e91a121adb5a",
"title": "Middlesex Water Announces Third Quarter 2024 Financial Results By Investing.com",
"description": "Middlesex Water Announces Third Quarter 2024 Financial Results",
"keywords": "",
"snippet": "Diluted earnings per share of $0.80 for the quarter, an increase of 42.9% in comparison to the prior year\n\nCommon dividend increased by 4.62%.\n\nISELIN, N.J., Oc...",
"url": "https://www.investing.com/news/press-releases/middlesex-water-announces-third-quarter-2024-financial-results-93CH-3695859",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T20:52:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSEX",
"name": "Middlesex Water Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 92.25384,
"sentiment_score": 0.3082,
"highlights": [
{
"highlight": "., Oct. 31, 2024 (GLOBE NEWSWIRE) -- <em[+202 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Information about Middlesex Water's Inve[+370 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "The company and its subsidiaries form th[+260 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "This press release contains forwardloo[+340 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Middlesex</em> <em>Water</em> Announces Third Quarter 2024 Financial Results By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "88bbf815-dbac-4580-82e7-de26f837f675",
"title": "Middlesex Water Announces Third Quarter 2024 Financial Results",
"description": "Middlesex Water Announces financial results for Third Quarter 2024...",
"keywords": "Nasdaq:MSEX, Middlesex Water Company, third quarter earnings, dividend increase, new jersey utilities, Nadine Leslie, water sector, infrastructure investment",
"snippet": "Diluted earnings per share of $0.80 for the quarter, an increase of 42.9% in comparison to the prior year\n\nCommon dividend increased by 4.62%.\n\nISELIN, N.J., Oc...",
"url": "https://www.globenewswire.com/news-release/2024/10/31/2973070/8240/en/Middlesex-Water-Announces-Third-Quarter-2024-Financial-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/09680b6c-76a9-473a-9eaf-23a286d0a0a3",
"language": "en",
"published_at": "2024-10-31T20:35:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "MSEX",
"name": "Middlesex Water Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Utilities",
"match_score": 94.40263,
"sentiment_score": 0.3082,
"highlights": [
{
"highlight": "., Oct. 31, 2024 (GLOBE NEWSWIRE) -- <em[+203 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Information about Middlesex Water’s In[+372 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "The company and its subsidiaries form th[+260 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "This press release contains “forward?[+359 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Middlesex</em> <em>Water</em> Announces Third Quarter 2024 Financial Results",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "291f7106-3ada-406d-82c6-ddd28b296d4c",
"title": "Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf By Investing.com",
"description": "Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf",
"keywords": "",
"snippet": "BOULDER, CO / ACCESSWIRE / October 31, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn ...",
"url": "https://www.investing.com/news/press-releases/sonoma-pharmaceuticals-to-exhibit-at-medica-2024-in-dasseldorf-93CH-3696125",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png",
"language": "en",
"published_at": "2024-10-31T23:28:04.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "SNOA",
"name": "Sonoma Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 101.39986,
"sentiment_score": 0.390882,
"highlights": [
{
"highlight": "BOULDER, CO / ACCESSWIRE / October 31, 2[+61 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:SNOA</em>), a global healthc[+322 characters]",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sonoma</em> <em>Pharmaceuticals</em>[+198 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Interested parties are invited to visit [+308 characters]",
"sentiment": 0.9647,
"highlighted_in": "main_text"
},
{
"highlight": "MEDICA serves as an exceptional venue fo[+259 characters]",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sonoma</em> <em>Pharmaceuticals</em>[+266 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Forward-Looking Statements\n\nExcept for h[+340 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": ", <em>Inc</em>. and its subsidiaries (th[+13 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sonoma</em> <em>Pharmaceuticals</em>[+288 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "[email protected]\n\nWebsite: www.sonoma[+315 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Sonoma</em> <em>Pharmaceuticals</em> to Exhibit at MEDICA 2024 in Düsseldorf By Investing.com",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "276c1c49-1c4c-46b3-90cd-208a809189ce",
"title": "Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2024 Earnings Call Transcript",
"description": "Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ETCompany ParticipantsTina Ventura - Chief Investor...",
"keywords": "",
"snippet": "Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET\n\nCompany Participants\n\nTina Ventura - Chief Investor R...",
"url": "https://seekingalpha.com/article/4731686-madrigal-pharmaceuticals-inc-mdgl-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:50:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MDGL",
"name": "Madrigal Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 163.7934,
"sentiment_score": 0.167625,
"highlights": [
{
"highlight": "<em>Madrigal</em> <em>Pharmaceuticals</e[+17 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:MDGL</em>) Q3 2024 Earnings [+326 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome to <em>Madrigal</em> <em>Pharmac[+288 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Madrigal</em> <em>Pharmaceuticals</em>, <em>Inc</em>. (MDGL) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "198356f9-86c5-4206-9474-4e0e0d4f9a8b",
"title": "Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript",
"description": "Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsKaren Hunady - Director of Investor...",
"keywords": "",
"snippet": "Syros Pharmaceuticals, Inc (NASDAQ:SYRS) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET\n\nCompany Participants\n\nKaren Hunady - Director of Investor...",
"url": "https://seekingalpha.com/article/4731657-syros-pharmaceuticals-inc-syrs-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:21:11.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SYRS",
"name": "Syros Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 171.02444,
"sentiment_score": 0.236533,
"highlights": [
{
"highlight": "<em>Syros</em> <em>Pharmaceuticals</em>,[+352 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "- Piper Sandler\n\nPhil Nadeau - TD Cowen\n[+205 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Syros</em> <em>Pharmaceuticals</em>, <em>Inc</em> (SYRS) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0LC7.L",
"name": "Syros Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 155.58905,
"sentiment_score": 0.236533,
"highlights": [
{
"highlight": "<em>Syros</em> <em>Pharmaceuticals</em>,[+343 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "- Piper Sandler\n\nPhil Nadeau - TD Cowen\n[+205 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Syros</em> <em>Pharmaceuticals</em>, <em>Inc</em> (SYRS) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "3d76ebb0-f63e-4886-89ed-01723e27f58a",
"title": "Agios Pharmaceuticals, Inc. (AGIO) Q3 2024 Earnings Call Transcript",
"description": "Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ETCompany ParticipantsChris Taylor - Vice President,...",
"keywords": "",
"snippet": "Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET\n\nCompany Participants\n\nChris Taylor - Vice President, Inv...",
"url": "https://seekingalpha.com/article/4731644-agios-pharmaceuticals-inc-agio-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:16:09.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AGIO",
"name": "Agios Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 167.0918,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Agios</em> <em>Pharmaceuticals</em>,[+14 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:AGIO</em>) Q3 2024 Earnings [+321 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Agios</em> <em>Pharmaceuticals</em>, <em>Inc</em>. (AGIO) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "0HB0.L",
"name": "Agios Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 151.67665,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Agios</em> <em>Pharmaceuticals</em>,[+14 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Agios</em> <em>Pharmaceuticals</em>, <em>Inc</em>. (AGIO) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "29fd17ad-5add-4b04-b888-f7945c3ae0af",
"title": "Japan Tobacco Inc. (JAPAY) Q3 2024 Earnings Call Transcript",
"description": "Japan Tobacco Inc. (OTCPK:JAPAY) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ETCompany ParticipantsHiromasa Furukawa - Chief Financial Officer...",
"keywords": "",
"snippet": "Japan Tobacco Inc. (OTCPK:JAPAY) Q3 2024 Earnings Conference Call October 31, 2024 4:00 AM ET\n\nCompany Participants\n\nHiromasa Furukawa - Chief Financial Officer...",
"url": "https://seekingalpha.com/article/4731840-japan-tobacco-inc-japay-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T23:23:05.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "JAPAY",
"name": "Japan Tobacco Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 176.614,
"sentiment_score": 0.222125,
"highlights": [
{
"highlight": "<em>Japan</em> <em>Tobacco</em> <em>Inc<[+5 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "and Deputy CEO\n\nConference Call Particip[+324 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tobacco</em> <em>Inc</em>. today.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Japan</em> <em>Tobacco</em> <em>Inc</em>. (<em>JAPAY</em>) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "JAPAF",
"name": "Japan Tobacco Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 126.36809,
"sentiment_score": 0.222125,
"highlights": [
{
"highlight": "<em>Japan</em> <em>Tobacco</em> <em>Inc<[+5 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "and Deputy CEO\n\nConference Call Particip[+324 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Tobacco</em> <em>Inc</em>. today.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Japan</em> <em>Tobacco</em> <em>Inc</em>. (JAPAY) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "139f9d0a-9d7b-40fb-9192-73333b8ce271",
"title": "Cactus Inc. (WHD) Q3 2024 Earnings Call Transcript",
"description": "Cactus Inc. (NYSE:WHD) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ETCompany ParticipantsJohn Fitzgerald - Director of Corporate Development...",
"keywords": "",
"snippet": "Cactus Inc. (NYSE:WHD) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET\n\nCompany Participants\n\nJohn Fitzgerald - Director of Corporate Development ...",
"url": "https://seekingalpha.com/article/4731772-cactus-inc-whd-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T20:50:28.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "WHD",
"name": "Cactus, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 108.34319,
"sentiment_score": 0.269325,
"highlights": [
{
"highlight": "<em>Cactus</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:WHD</em>) Q3 2024 Earnings Con[+322 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Welcome to the <em>Cactus</em> Q3 2024 E[+307 characters]",
"sentiment": 0.9493,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cactus</em> <em>Inc</em>. (WHD) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "a8813fab-ac73-4378-8e09-2d8cf7a6363d",
"title": "Renesas Electronics Corporation (RNECF) Q3 2024 Earnings Call Transcript",
"description": "Renesas Electronics Corporation (OTCPK:RNECF) Q3 2024 Results Conference Call October 30, 2024 9:00 PM ETCompany ParticipantsHidetoshi Shibata -...",
"keywords": "",
"snippet": "Renesas Electronics Corporation (OTCPK:RNECF) Q3 2024 Results Conference Call October 30, 2024 9:00 PM ET\n\nCompany Participants\n\nHidetoshi Shibata - Representat...",
"url": "https://seekingalpha.com/article/4731836-renesas-electronics-corporation-rnecf-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T23:15:21.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "RNECY",
"name": "Renesas Electronics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 163.34616,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Renesas</em> <em>Electronics</em> <e[+342 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Renesas</em> <em>Electronics</em> <em>Corporation</em> (RNECF) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "RNECF",
"name": "Renesas Electronics Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 215.00006,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Renesas</em> <em>Electronics</em> <e[+342 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Renesas</em> <em>Electronics</em> <em>Corporation</em> (<em>RNECF</em>) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "ce4dae7f-366e-46df-91ca-2bdc62e11bfb",
"title": "Merck Narrows Sales Outlook With Gardasil Lagging in China",
"description": "Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight quarter in China.",
"keywords": "HPV vaccine, Merck & Co., Gardasil sales, China vaccine approval, Keytruda sales",
"snippet": "Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight quarter in China.\n\nSales of the Gard...",
"url": "https://www.livemint.com/news/world/merck-narrows-sales-outlook-with-gardasil-lagging-in-china-11730415887467.html",
"image_url": "https://images.livemint.com/img/2018/12/28/1600x900/News_-_world_1545994908237.jpg",
"language": "en",
"published_at": "2024-10-31T23:04:46.000000Z",
"source": "livemint.com",
"relevance_score": null,
"entities": [
{
"symbol": "RXDX",
"name": "Prometheus Biosciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.944973,
"sentiment_score": -0.5423,
"highlights": [
{
"highlight": "In 2023, the company paid almost $11 bil[+280 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XLRN",
"name": "Acceleron Pharma Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.24669,
"sentiment_score": 0.3818,
"highlights": [
{
"highlight": "That followed its $11 billion acquisitio[+270 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "1cb51e92-7a95-4b93-b890-3ed208809fb7",
"title": "Apple Disappoints Investors With Tepid Forecast, China Weakness",
"description": "Apple Inc., heading into its most critical sales period of the year, sparked fresh concerns about revenue growth and lingering weakness in an intensely competitive China market.",
"keywords": "Apple Inc., revenue growth, China market, iPhone sales, artificial intelligence",
"snippet": "Apple Inc., heading into its most critical sales period of the year, sparked fresh concerns about revenue growth and lingering weakness in an intensely competit...",
"url": "https://www.livemint.com/news/world/apple-disappoints-investors-with-tepid-forecast-china-weakness-11730415829873.html",
"image_url": "https://images.livemint.com/img/2018/12/28/1600x900/News_-_world_1545994908237.jpg",
"language": "en",
"published_at": "2024-10-31T23:03:49.000000Z",
"source": "livemint.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 25.373096,
"sentiment_score": 0.385982,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>., heading in[+331 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Earnings were 97 cents a share, though t[+286 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Investors have been betting that <em>App[+216 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> hadn’t released major u[+279 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "After going roughly 18 months without an[+144 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Earlier this month, <em>Apple</em> refre[+301 characters]",
"sentiment": 0.7543,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> has yet to announce plans[+312 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "More broadly, <em>Apple</em> Intelligenc[+328 characters]",
"sentiment": 0.4391,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> now allows third-party ap[+290 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "But <em>Apple</em> is making a fresh run[+133 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> Disappoints Investors With Tepid Forecast, China Weakness",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "APC.DE",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Technology",
"match_score": 25.373053,
"sentiment_score": 0.385982,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>., heading in[+331 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Earnings were 97 cents a share, though t[+286 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Investors have been betting that <em>App[+216 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> hadn’t released major u[+279 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "After going roughly 18 months without an[+144 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Earlier this month, <em>Apple</em> refre[+301 characters]",
"sentiment": 0.7543,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> has yet to announce plans[+312 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "More broadly, <em>Apple</em> Intelligenc[+328 characters]",
"sentiment": 0.4391,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> now allows third-party ap[+290 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "But <em>Apple</em> is making a fresh run[+133 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> Disappoints Investors With Tepid Forecast, China Weakness",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "AAPL.MX",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Technology",
"match_score": 25.372078,
"sentiment_score": 0.385982,
"highlights": [
{
"highlight": "<em>Apple</em> <em>Inc</em>., heading in[+331 characters]",
"sentiment": 0.128,
"highlighted_in": "main_text"
},
{
"highlight": "Earnings were 97 cents a share, though t[+286 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Investors have been betting that <em>App[+216 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> hadn’t released major u[+279 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "After going roughly 18 months without an[+144 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Earlier this month, <em>Apple</em> refre[+301 characters]",
"sentiment": 0.7543,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> has yet to announce plans[+312 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "More broadly, <em>Apple</em> Intelligenc[+328 characters]",
"sentiment": 0.4391,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> now allows third-party ap[+290 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "But <em>Apple</em> is making a fresh run[+133 characters]",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> Disappoints Investors With Tepid Forecast, China Weakness",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "b8666d8a-200a-4e60-a4a0-623083abb8e2",
"title": "AIXTRON SE (AIXXF) Q3 2024 Earnings Call Transcript",
"description": "AIXTRON SE (OTCPK:AIXXF) Q3 2024 Results Conference Call October 31, 2024 10:00 AM ETCompany ParticipantsChristian Ludwig - Head of Investor RelationsFelix...",
"keywords": "",
"snippet": "AIXTRON SE (OTCPK:AIXXF) Q3 2024 Results Conference Call October 31, 2024 10:00 AM ET\n\nCompany Participants\n\nChristian Ludwig - Head of Investor Relations\n\nFeli...",
"url": "https://seekingalpha.com/article/4731833-aixtron-se-aixxf-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T23:02:11.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AIIXY",
"name": "AIXTRON SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 109.8962,
"sentiment_score": 0.236533,
"highlights": [
{
"highlight": "<em>AIXTRON</em> <em>SE</em> (OTCPK:AIXX[+332 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "- ODDO BHF\n\nGustav Froberg - Berenberg\n\n[+286 characters]",
"sentiment": 0.7096,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AIXTRON</em> <em>SE</em> (AIXXF) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "5590d569-8807-445a-8b9c-450c74b6d7d3",
"title": "Federal Signal Corporation (FSS) Q3 2024 Earnings Call Transcript",
"description": "Federal Signal Corporation (NYSE:FSS) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ETCompany ParticipantsFelix Boeschen – Vice...",
"keywords": "",
"snippet": "Federal Signal Corporation (NYSE:FSS) Q3 2024 Earnings Conference Call October 31, 2024 10:00 AM ET\n\nCompany Participants\n\nFelix Boeschen – Vice President-Cor...",
"url": "https://seekingalpha.com/article/4731754-federal-signal-corporation-fss-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T20:20:07.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "FSS",
"name": "Federal Signal Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 144.22195,
"sentiment_score": 0.233433,
"highlights": [
{
"highlight": "<em>Federal</em> <em>Signal</em> <em>Cor[+347 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Dave Storms – Stonegate\n\nOperator\n\nGre[+308 characters]",
"sentiment": 0.7003,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Federal</em> <em>Signal</em> <em>Corporation</em> (FSS) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e9273e03-b871-44e6-bed2-e2eb008175fb",
"title": "Murphy USA Inc. (MUSA) Q3 2024 Earnings Call Transcript",
"description": "Murphy USA Inc. (NYSE:MUSA) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ETCompany ParticipantsChristian Pikul – Vice President-Investor...",
"keywords": "",
"snippet": "Murphy USA Inc. (NYSE:MUSA) Q3 2024 Earnings Conference Call October 31, 2024 11:00 AM ET\n\nCompany Participants\n\nChristian Pikul – Vice President-Investor Rel...",
"url": "https://seekingalpha.com/article/4731678-murphy-usa-inc-musa-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T18:41:04.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MUSA",
"name": "Murphy USA Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 135.42462,
"sentiment_score": 0.27958,
"highlights": [
{
"highlight": "<em>Murphy</em> <em>USA</em> <em>Inc</em[+2 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NYSE:MUSA</em>) Q3 2024 Earnings Co[+334 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "I would like to welcome everyone to the [+313 characters]",
"sentiment": 0.8519,
"highlighted_in": "main_text"
},
{
"highlight": "For further discussion of risk factors, [+345 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Murphy</em> <em>USA</em> <em>Inc</em>. (MUSA) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "28458d5c-c31d-4c77-b3aa-1796342952b6",
"title": "argenx SE (ARGX) Q3 2024 Earnings Call Transcript",
"description": "argenx SE (NASDAQ:ARGX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsBeth DelGiacco – Vice President, Corporate...",
"keywords": "",
"snippet": "argenx SE (NASDAQ:ARGX) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET\n\nCompany Participants\n\nBeth DelGiacco – Vice President, Corporate Communi...",
"url": "https://seekingalpha.com/article/4731600-argenx-se-argx-q3-2024-earnings-call-transcript",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-10-31T17:08:03.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ARGX.BR",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "be",
"type": "equity",
"industry": "Healthcare",
"match_score": 111.46083,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>argenx</em> <em>SE</em> (NASDAQ:ARGX[+338 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>argenx</em> <em>SE</em> (ARGX) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "A1RG34.SA",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 111.436615,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>argenx</em> <em>SE</em> (NASDAQ:ARGX[+338 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>argenx</em> <em>SE</em> (ARGX) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ARGNF",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 111.385895,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>argenx</em> <em>SE</em> (NASDAQ:ARGX[+338 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>argenx</em> <em>SE</em> (ARGX) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "ARGX",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 126.35746,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>argenx</em> <em>SE</em> (<em>NASDAQ:[+347 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>argenx</em> <em>SE</em> (ARGX) Q3 2024 Earnings Call Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSCL.SN",
"name": "MORGAN STANLEY",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 25.133291,
"sentiment_score": 0.273,
"highlights": [
{
"highlight": "Financial Officer\n\nKaren Massey – Chie[+353 characters]",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Stanley</em>\n\nCharles Pitman-King ?[+349 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 5121,
"sentiment_avg": 0.2831047511326189
}
]
}
Other details
Entity count
- 32,647